When Compounded GLP-1 Medications Are Considered In some cases, patients may be unable to continue FDA-approved GLP-1 medications due to: Significant side effects despite careful dose titration Intolerance to specific formulations Insurance denial combined with unaffordable out-of-pocket costs In these situations, compounded GLP-1 medications may be considered as an alternative under the supervision of a licensed medical provider
Additional information Supported by Grants KO1 NR010548, RO1 HL69170, the Children's Healthcare of Atlanta Center for Developmental Lung Biology, and Grant UL1 RR025008 from the Clinical and Translational Science Award Program Rights and permissions About this article Cite this article Fitzpatrick, A., Teague, W., Burwell, L
At Batley Pharmacy, we understand that every patients journey is entirely unique
Mission Connection is here to help you or your loved one take the next steps towards an improved mental well-being